Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Neoplasms 2NSCLC 2Lymphoma, Non-Hodgkin 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Solid Tumor Regardless of Localization and Stage 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Neoplasms, Second Primary 1Multiple Myeloma 1Lymphoma, Extranodal NK-T-Cell 1Localized Advanced Rectal Adenocarcinoma 1Liver Neoplasms 1HER-2 Negative Breast Cancer 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Acute Kidney Injury 1

Interventions

Fentanyl 9Acetaminophen 5Zoledronic Acid 4Oxycodone 4Ketamine 4Bupivacaine 4Sufentanil 3Hydromorphone 3Diclofenac 3Ropivacaine 2Pregabalin 2Morphine 2Ketorolac 2Ibuprofen 2Ibandronic Acid 2Esketamine 2Epinephrine 2naloxegol 1chloroprocaine 1acetaminophen, aspirin, caffeine drug combination 1Varenicline 1Uterine Artery Embolization 1Ultracet 1Therapeutics 1Propofol 1Pamidronate 1Oxygen 1Nitrous Oxide 1Naproxen 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pain × Drug Therapy × Clear all
NCT00380874 2021-02-11

Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer

Pfizer

Phase 4 Terminated
64 enrolled 10 charts

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡